<p>Arthur F. Golden, a director of Turn Therapeutics Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Turn Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-113841), on November 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

TTRX

<p>Arthur F. Golden, a director at Turn Therapeutics Inc., has acquired common shares of the company. This information was originally published by Turn Therapeutics Inc. via the EDGAR system of the U.S. Securities and Exchange Commission.</p>

Director Arthur F. Golden Reports Acquisition of Turn Therapeutics Inc. Common Shares